Search for: "J & B Importers, Inc." Results 101 - 120 of 1,259
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 May 2017, 4:37 am by Eugene Volokh
Right to Life, Inc., 551 U.S. 449, 468 (2007) (lead opinion) (citation omitted) and at 495 (Scalia, J., concurring in part and concurring in the judgment) (likewise rejecting a test based on speaker motivation). [read post]
6 Feb 2015, 11:19 am by Dan Hepburn
Top Line Industries Inc., 1995 BCCA 2305 (“Top Line”) resulted in the enactment of section 73.1, which modified the effect of section 73. [read post]
18 Sep 2020, 1:10 am by Michael Douglas
On 14 September, Thawley J refused that application: Australian Information Commissioner v Facebook Inc (No 2) [2020] FCA 1307. [read post]
1 Aug 2011, 7:55 am by Eric Schweibenz
According to the Notice of Investigation, the ITC has identified the following entities as the respondents in this investigation: Robert Bosch GmbH of Germany Bosch Security Systems, Inc. of Fairpoint, New York Samsung Techwin Co., Ltd. of Korea Samsung Opto-Electronics America Inc. d/b/a Samsung Techwin America, Inc. of Ridgefield Park, New Jersey Sony Corporation of Japan Sony Electronics, Inc. of San Diego, California In addition, Chief ALJ Paul… [read post]
20 Jan 2021, 8:49 am by Arnold Wadsworth Coggins
While district courts generally have inherent authority and discretion regarding the “manage[ment of] their own affairs so as to achieve the orderly and expeditious disposition of cases,” see PDC Consulting, Inc. v. [read post]
12 Jul 2010, 7:09 pm by Eric Schweibenz
By way of background, the Complainant in this investigation is Humanscale Corporation (“Humanscale”) and the Respondents are CompX International, Inc. and Waterloo Furniture Components Limited d/b/a CompX Waterloo (collectively, “CompX”). [read post]
In undoubtedly one of the most important decisions of the year so far, on 24 August 2021, the English Court of Appeal handed down its judgment in FibroGen v Akebia (FibroGen Inc v Akebia Therapeutics Inc [2021] EWCA Civ 1279), partially allowing FibroGen’s appeal, and so finding one of the ‘Family A’ patents, EP 823, valid and infringed. [read post]
16 May 2021, 9:01 pm by News Desk
In an April 30 warning letter, the FDA described a Jan.19, 2021, remote Foreign Supplier Verification Program (FSVP) inspection for J & L USA Inc. [read post]